Skip to content

Evaluation of Exoskeleton for Upper Limb Rehabilitation in Neurological Patients

Evaluation of the Use of Exoskeleton Systems for Upper Limb Rehabilitation in Neurological Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05280431
Acronym
PCP_EXOs
Enrollment
48
Registered
2022-03-15
Start date
2022-01-25
Completion date
2023-03-31
Last updated
2023-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurologic Disorder, Stroke

Brief summary

Acquired cerebrovascular trauma is the third most common cause of disability worldwide, resulting in long-term disability, limitation of activities of daily living, and reduced social participation. It is estimated that, within three months of the acute event, a high percentage of patients do not recover full function. 93% of these disabilities concern the upper limb. To induce optimal functional reorganization after the acute cerebrovascular events or neurodegenerative diseases affecting the central nervous system, robotic assistance allows intensive exercises with specific therapeutic purposes. Indeed, they enable an intensive, repetitive, and customizable therapeutic program that is in line with the principles underlying motor learning. Clinical investigation is needed to assess the efficacy of the proposed new technologies (AGREE and FEXO exoskeleton) and to guide subsequent developmental steps. Therefore, an exploratory clinical study is proposed to evaluate usability, tolerability, and safety, as well as to assess the effectiveness of the new technologies. The primary objective of this study is to examine the safety and tolerability of the new active exoskeletons for upper extremity rehabilitation and validate them in a controlled environment. Furthermore, efficacy will be examined as the secondary outcome.

Interventions

DEVICEAGREE exoskeleton

Upper limb exoskeleton with four actuated degrees of freedom (shoulder horizontal adduction/abduction, shoulder flexion/extension, humeral rotation, elbow flexion/extension), and one passive degree of freedom (wrist pronation/supination), implementing different rehabilitative strategies. The intervention consists of the execution of different exercises with the affected arm supported by the AGREE device. The subject is actively involved in the exercises and the system provides different kinds of assistance that can be tailored according to the patient's status. The following exercises can be performed: * anterior reaching (in a plane or in the space) * lateral elevation of the arm * hand to mouth movements with or without an object in the hand * moving objects (on a plane or in the space) * exergames. A subset of exercises is defined based on the patient's capability.

DEVICEFEXO exoskeleton

After patient's preparation (tDCS and FES) the FEXO assessment is conducted. The subject performs FEXO assessment games. This stage is also used to calibrate the reach and grasp movement intention EEG patterns. The movement is recorded using internal kinematic sensors; therefore, these measures can be extracted for both reaching and lifting movements. Trunk forward bending is measured to avoid compensatory movements when doing reaching assessment. The clinician then reviews the plan for today's session: game selection, number of repetitions and assistance levels. The patient gets ready to play the games and the clinician starts the first activity of the active stage of FEXO therapy. The patient plays the game and sees his own results. The clinician monitors patient activity, assistance levels, effort and signs of discomfort. The patient plays the next game and sees his own results, and the clinician checks the patient's progress with the results overview.

OTHERConventional therapy

It consists of a combination of different treatment modalities among the following, based on the patient's specific needs: * Upper limb passive motion * Occupational therapy exercises * Constraint-induced movement therapy * Upper limb active movement (reaching, grasping, elevation, spatial orientation) * Repetitive task training

Sponsors

Politecnico di Milano
CollaboratorOTHER
Fundación Tecnalia Research & Innovation
CollaboratorUNKNOWN
Casa di Cura Privata del Policlinico SpA
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* age between 18 and 85 years; * motor deficit of the upper limb induced by neurological diseases (e.g., stroke, multiple sclerosis); * time since the acute event of at least one month; * Trunk Control Test score ≥ 48.

Exclusion criteria

* global aphasia; * presence of cognitive impairment; * severe unilateral spatial neglect; * Box and Block test \< 1; * Ashworth scale score ≥ 4; * total or severe impairment of visual acuity; * instability of clinical parameters or presence of severe comorbidities; * inadequate anthropometric measurements; * presence of any serious condition that may affect participation in the study (e.g., oncological, hepatic/renal, immune, metabolic/endocrine, psychiatric, respiratory or infectious disorders); * inability to comply with the protocol or to give informed consent.

Design outcomes

Primary

MeasureTime frameDescription
System Usability Scale (SUS)up to 5 weeksSUS is used to measure how easy or difficult the proposed system is to use

Secondary

MeasureTime frameDescription
Virtual Reality Questionnaire (VR)up to 5 weeksVR is used to measure how easy or difficult the virtual reality interface is to use
Fugl-Meyer Assessment Scale (FMA-UE)up to 5 weeksFMA-UE assesses sensorimotor status including items assessing upper extremity motion, balance, sensation and range of movement
Action Research Arm Test (ARAT)up to 5 weeksARAT is used to assess upper extremity performance (coordination, dexterity and functioning)
Modified Ashworth Scale (MAS)up to 5 weeksMAS is used to muscle quantified spasticity
Motricity Index (MI)up to 5 weeksMI is used to grade motor activity in muscles of the upper limb
Visual Analogue Scale (VAS)up to 5 weeksVAS is a psychometric response scales used to measure subjective pain
Technology Assessment Methods (TAM)up to 5 weeksTAM is an information systems theory that models how users come to accept and use a technology
Nine Hole Peg Test (9HPT)up to 5 weeks9HPT is used to measure finger dexterity in patients. The 9HPT administration consist of asking the subject to take the pegs from a container, one by one, and place them into the holes on the board, as quickly as possible
Number of Peaks (#Peaks) of the speed profileup to 5 weeksIf a point-to-point reaching movement has a low number of peaks, it means that few acceleration and deceleration periods are present
Smoothness described by the Teulings's index (TI)up to 5 weeksTI s the rate of change of the acceleration in a movement; a lower value of TI indicates a smoother movement
The absolute hand path error (e)up to 5 weekse is the area between the actual movement path and the straight line; this was considered an index of learning and a reduction of e indicates a better adaptation to the required task.
Event-Related Desynchronization and Synchronization (ERD/ERS) of the μ and β rhythmsup to 5 weeksMotor processing can result in changes of the ongoing EEG in form of an event-related desynchronization (ERD) or event-related synchronization (ERS). Spatial mapping of ERD/ERS can be used to study the dynamics of cortical activation patterns
Box and Block Test (BBT)up to 5 weeksBBT measures unilateral gross manual dexterity. The BBT administration consists of asking the subject to move, one by one, the maximum number of blocks from one compartment of a box to another of equal size, within 60 seconds

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026